Outcomes Network Graph
Outcomes Flow Chart
Conditions Resulting from Aspirin
User-reported conditions resulting from Aspirin based on their intuition.
| Resulting Condition | Agree |
|---|---|
| Tinnitus | 12% |
Treatment Effectiveness
User reported effectiveness ratings Aspirin for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Back Pain | 3% | 28% | 3% | 62% | 4% | 113 |
| Neck Pain | 4% | 30% | 9% | 53% | 4% | 79 |
| Arthritic Hips | 0% | 33% | 0% | 50% | 17% | 6 |
| Arthritis | 5% | 30% | 9% | 56% | 0% | 82 |
| Bunion | 0% | 25% | 0% | 75% | 0% | 4 |
| Chest Pain | 13% | 38% | 0% | 50% | 0% | 8 |
| Chronic Fatigue Syndrome | 1% | 28% | 5% | 58% | 8% | 150 |
| Chronic Pain Syndrome | 0% | 50% | 0% | 33% | 17% | 6 |
| Cluster Headaches | 3% | 28% | 7% | 48% | 14% | 29 |
| Fibromyalgia | 2% | 18% | 7% | 72% | 1% | 85 |
| Hemicrania Continua | 0% | 6% | 3% | 86% | 6% | 35 |
| Knee Pain | 5% | 32% | 3% | 56% | 3% | 62 |
| Lower Back Pain | 100% | 0% | 0% | 0% | 0% | 1 |
| Mitral Valve Prolapse | 1% | 27% | 4% | 64% | 4% | 162 |
| Osteoarthritis | 8% | 28% | 0% | 64% | 0% | 25 |
| Restless Legs Syndrome | 0% | 12% | 8% | 76% | 4% | 25 |
| Scoliosis | 0% | 33% | 8% | 58% | 0% | 12 |
| Shoulder Pain | 7% | 30% | 3% | 56% | 5% | 61 |
| TMJ Disorder | 0% | 53% | 0% | 42% | 5% | 19 |
Side Effects
User-reported side effects of Aspirin
| Side Effect | Percent of Reports Aspirin |
|---|---|
| Diarrhea | 2% |
| Heartburn | 17% |
| Stomach Pain | 21% |
| Generalized Increase in Pain | 5% |
| Seeing Stars | 4% |
| Vomiting | 4% |
| Nausea | 12% |
Outcomes
Below is the degree of change seen after Aspirin is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Aspirin Info
| Property | Value |
|---|---|
| Variable Name | Aspirin |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-10-11 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Kurtosis | 99.068614489687 |
| Mean | 62.19472125 milligrams |
| Median | 61.5 milligrams |
| Minimum Allowed Value | 0 milligrams |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 58 |
| Number of Measurements | 27 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 27 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 4.2851940707025 |
| Unit | Milligrams |
| User Variables | 14 |
| UPC | 301130416908 |
| Variable Category | Treatments |
| Variable ID | 5734741 |
| Variance | 56.272458355368 |